Zeitschrift für klinische Immunologie und Forschung

Our Cure for Leukemia and Lymphoma: How Our Diversity Insures Our Survival and Leaves No Patient Behind

Thomas Clayton Coleman

This year in hospitals across the nation tens of thousands of our loved ones will be diagnosed with some form of Leukaemia or Lymphoma or any number of blood born life-threatening illnesses and many of them will die hopelessly waiting for a viable matching donor that will never come. But what if I were to tell you that those days of waiting are to be over.